Gut Microbiota in Multiple Sclerosis: Possible Influence of Immunomodulators

Objectives Differences in gut bacteria have been described in several autoimmune disorders. In this exploratory pilot study, we compared gut bacteria in patients with multiple sclerosis and healthy controls and evaluated the influence of glatiramer acetate and vitamin D treatment on the microbiota....

Full description

Saved in:

Bibliographic Details
Published in:	Journal of investigative medicine Vol. 63; no. 5; pp. 729 - 734
Main Authors:	Cantarel, Brandi L., Waubant, Emmanuelle, Chehoud, Christel, Kuczynski, Justin, DeSantis, Todd Z., Warrington, Janet, Venkatesan, Arun, Fraser, Claire M., Mowry, Ellen M.
Format:	Journal Article
Language:	English
Published:	Los Angeles, CA SAGE Publications 01.06.2015
Subjects:	Adjuvants, Immunologic - pharmacology Adjuvants, Immunologic - therapeutic use Adult Cholecalciferol - pharmacology Cholecalciferol - therapeutic use Dietary Supplements Female Gastrointestinal Microbiome - drug effects Gastrointestinal Microbiome - physiology Glatiramer Acetate - pharmacology Glatiramer Acetate - therapeutic use Humans Immunologic Factors - pharmacology Immunologic Factors - therapeutic use Middle Aged Multiple Sclerosis, Relapsing-Remitting - diagnosis Multiple Sclerosis, Relapsing-Remitting - drug therapy Pilot Projects gut microbiome autoimmunity glatiramer acetate multiple sclerosis vitamin D
ISSN:	1081-5589, 1708-8267
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!